z-logo
open-access-imgOpen Access
A retrospective clinico-pathologic analysis of cemento-osseous dysplasia in a South African patient population
Author(s) -
Mouna Mohamed Salim Benaessa,
F. M. Mahomed,
S Ngwenya
Publication year - 2020
Publication title -
african health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 44
eISSN - 1729-0503
pISSN - 1680-6905
DOI - 10.4314/ahs.v19i4.38
Subject(s) - medicine , osteomyelitis , fibrous dysplasia , dentistry , population , maxilla , mandible (arthropod mouthpart) , surgery , botany , environmental health , biology , genus
Background: Cemento-osseous dysplasia (COD) is a fibro-osseous jaw bone lesion. The affected bone in COD progressively becomes sclerotic, poorly vascularized and susceptible to secondary osteomyelitis. Objective: To provide a clinico-pathologic appraisal of COD in a South African patient population. Methods: Archived records of 133 patients diagnosed with COD were reviewed for patient demographics, COD location,COD type, osteomyelitis or simple bone cyst secondary to COD. Results: The mean age was 53.4 ± 13.5 years with a 94.7% female predilection. COD mainly affected the mandible (57.1%),followed by involvement of both jaws (38.3%) and maxilla (4.5%). Florid COD was the most prevalent (69.9%), followed byfocal COD (18%) and periapical COD (12%). Florid COD showed a clear trend of increasing with age, peaking in the sixthdecade and decreasing thereafter. Osteomyelitis and simple bone cyst presented as complications of COD in 74.4% and 5.3%of cases respectively, while 21.8% of all cases of jaw osteomyelitis during the study period were secondary to COD. Conclusion: A higher frequency of jaw osteomyelitis secondary to COD was found compared to previous studies. No significantassociation was shown between any of the COD types and secondary osteomyelitis. Keywords: Cemento-osseous dysplasia; South Africa; patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here